BOSTON RESEARCH & MANAGEMENT INC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001259261

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHigh Turnover how tags are computed

Q1 2026 · 115 positions · Total reported value $428.29M · Top-10 concentration 28.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 32.3% · 3 new · 34 cut · 3 exited

Active Share (vs S&P 500): 67.5% · vs QQQ: 77.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.6% · vs SPY -3.7% · Prev Value $452.63M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +4.9% · vs SPY +2.8% · Latest Value $453.36M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, BOSTON RESEARCH & MANAGEMENT INC disclosed 115 equity positions with a combined reported value of $428.29M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 28.1% of reported value. HoldingsHub classifies the profile as Small / High Turnover.

The largest disclosed positions as of Q1 2026 were IVV ($18.99M), WMT ($13.69M), MSFT ($13.64M). By sector, the heaviest allocations are Consumer Discretionary 23.0%, Technology 12.9%. Versus the prior quarter, allocation shifted toward Energy (+3.8pp), Other (+1.8pp) and away from Technology (-2.3pp), Consumer Staples (-3.4pp).

Versus the prior quarter, BOSTON RESEARCH & MANAGEMENT INC opened 3 new positions, trimmed 34 and fully exited 3, a turnover rate of 32.3% of positions. The portfolio's overlap with the prior quarter was 92% of names.

The largest new positions opened in Q1 2026 were ADM ($209.35K), TXN ($205.79K).

Of the 3 positions fully exited versus the prior quarter, the largest were IYK ($702.66K), YUM ($653.53K), BA ($282.26K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • ADM ARCHER DANIELS MIDLAND CO · $209.35K
  • TXN TEXAS INSTRS INC · $205.79K

Fully Exited (vs previous quarter)

  • IYK ISHARES TR · prev qtr: $702.66K
  • YUM YUM BRANDS INC · prev qtr: $653.53K
  • BA BOEING CO · prev qtr: $282.26K
  • A AGILENT TECHNOLOGIES INC · prev qtr: $236.35K
  • CHRW C H ROBINSON WORLDWIDE IN · prev qtr: $223.46K
  • YUMC YUM CHINA HLDGS INC · prev qtr: $209.54K
  • CVS CVS HEALTH CORP · prev qtr: $201.50K
  • ESBA EMPIRE ST RLTY OP L P · prev qtr: $67.75K

Insider Transactions (Form 4)

Latest BOSTON RESEARCH & MANAGEMENT INC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Boston Research & Management is an SEC-registered 13F filer based in Manchester, MA, United States. As of Q2 2026 it reported 121 US equity positions with a combined value of $452.63M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MANCHESTER, MA, United States
  • SEC registration: 801-39603 (status: Approved), registered 1991-07-31
  • Regulatory AUM (Form ADV): $676.19M as of 2026-03-25
  • Client mix (by RAUM): individual investors 100%, pension and profit-sharing plans 0%
  • Website: bostonrm.com

Portfolio Structure

  • 121 positions · $452.63M reported value (Q2 2026)
  • Top 10 holdings = 29.9% of reported value
  • Largest position: IVV (ISHARES TR) at 4.8%
  • Average position size: $3.74M

Sector Tilt

  • Consumer Discretionary 22.4%
  • Information Technology 13.6%
  • Health Care 10.6%
  • (classified holdings cover 78% of value)

Quarterly Activity

  • Q2 2026: 6 new, 10 added, 39 reduced
  • 66 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 12.9%
Health Care 10.6%
Financials 6.7%
Energy 3.8%
Other 31.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 29.07K $18.99M 4.43%
4.43%
Reduce
2 110.12K $13.69M 3.20%
3.20%
Reduce
3 36.86K $13.64M 3.19%
3.19%
Reduce
4 44.12K $12.69M 2.96%
2.96%
Reduce
5 49.67K $12.61M 2.94%
2.94%
Reduce
6 48.35K $10.52M 2.46%
2.46%
Reduce
7 125.53K $9.74M 2.27%
2.27%
Reduce
8 32.36K $9.52M 2.22%
2.22%
Reduce
9 75.73K $9.41M 2.20%
2.20%
Hold
10 201.37K $9.34M 2.18%
2.18%
Reduce
11 53.19K $9.02M 2.11%
2.11%
Reduce
12 17.67K $8.47M 1.98%
1.98%
Reduce
13 16.75K $8.37M 1.95%
1.95%
Reduce
14 66.57K $8.01M 1.87%
1.87%
Add
15 15.77K $7.82M 1.82%
1.82%
Add
16 169.47K $7.68M 1.79%
1.79%
Add
17 64.64K $7.67M 1.79%
1.79%
Hold
18 24.10K $7.49M 1.75%
1.75%
Hold
19 100.82K $7.24M 1.69%
1.69%
Reduce
20 103.31K $7.21M 1.68%
1.68%
Reduce
21 33.58K $6.99M 1.63%
1.63%
Hold
22 73.98K $6.87M 1.60%
1.60%
Reduce
23 39.05K $6.81M 1.59%
1.59%
Hold
24 46.80K $6.76M 1.58%
1.58%
Reduce
25 11.16K $6.75M 1.57%
1.57%
Reduce
26 56.13K $6.71M 1.57%
1.57%
Reduce
27 17.95K $6.52M 1.52%
1.52%
Reduce
28 69.55K $6.30M 1.47%
1.47%
Hold
29 23.31K $6.22M 1.45%
1.45%
Reduce
30 59.68K $6.13M 1.43%
1.43%
Add
31 45.71K $5.99M 1.40%
1.40%
Add
32 74.11K $5.64M 1.32%
1.32%
Reduce
33 40.29K $5.53M 1.29%
1.29%
Reduce
34 41.56K $5.49M 1.28%
1.28%
Add
35 107.99K $5.42M 1.27%
1.27%
Hold
36 10.81K $5.32M 1.24%
1.24%
Add
37 33.75K $5.24M 1.22%
1.22%
Reduce
38 60.67K $5.17M 1.21%
1.21%
Add
39 95.06K $4.94M 1.15%
1.15%
Hold
40 67.64K $4.82M 1.13%
1.13%
Hold
41 48.38K $4.66M 1.09%
1.09%
Add
42 18.50K $4.59M 1.07%
1.07%
Reduce
43 74.73K $4.58M 1.07%
1.07%
Reduce
44 7.01K $4.56M 1.06%
1.06%
Reduce
45 4.83K $4.45M 1.04%
1.04%
Add
46 50.55K $4.38M 1.02%
1.02%
Add
47 42.44K $4.17M 0.97%
0.97%
Add
48 46.83K $4.13M 0.96%
0.96%
Hold
49 4.11K $4.02M 0.94%
0.94%
Add
50 107.87K $4.01M 0.94%
0.94%
Add

FAQ

What did BOSTON RESEARCH & MANAGEMENT INC buy in 2026-Q1?

In its 2026-Q1 13F filing, BOSTON RESEARCH & MANAGEMENT INC reported 115 equity positions worth $428.29M in aggregate; its largest disclosed positions were IVV ($18.99M), WMT ($13.69M), MSFT ($13.64M).

How large is BOSTON RESEARCH & MANAGEMENT INC's portfolio?

BOSTON RESEARCH & MANAGEMENT INC reported $428.29M of long equity holdings across 115 positions as of 2026-Q1. Top-10 holdings account for 28.1% of reported value.

What is BOSTON RESEARCH & MANAGEMENT INC's investment style?

HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/boston-research-and-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →